Literature DB >> 2597775

Severe neutropenia associated with large granular lymphocyte lymphocytosis: successful control with cyclosporin A.

E Pastor1, M J Sayas.   

Abstract

Lymphocytosis of large granular lymphocytes (LGL) with severe neutropenia was diagnosed in a 42-years old patient. After prednisone yielded only a transitory effect, long lasting improvement was achieved by treatment with cyclosporin A.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2597775     DOI： 10.1007/bf00329495

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


  5 in total

1.  Cyclosporin A in adult-onset cyclic neutropenia.

Authors:  C Selleri; L Catalano; F Alfinito; G De Rosa; S Vaglio; B Rotoli
Journal:  Br J Haematol       Date:  1988-01       Impact factor: 6.998

2.  Fulminant clonal expansion of large granular lymphocytes. Characterization of their morphology, phenotype, genotype, and function.

Authors:  T Ohno; T Kanoh; Y Arita; H Fujii; K Kuribayashi; T Masuda; Y Horiguchi; M Taniwaki; T Nosaka; M Hatanaka
Journal:  Cancer       Date:  1988-11-01       Impact factor: 6.860

3.  Adult-onset cyclic neutropenia is associated with increased large granular lymphocytes.

Authors:  T P Loughran; E A Clark; T H Price; W P Hammond
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

4.  Large granular lymphocyte leukemia. Report of 38 cases and review of the literature.

Authors:  T P Loughran; G Starkebaum
Journal:  Medicine (Baltimore)       Date:  1987-09       Impact factor: 1.889

5.  Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia.

Authors:  T P Loughran; M E Kadin; G Starkebaum; J L Abkowitz; E A Clark; C Disteche; L G Lum; S J Slichter
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391
  5 in total
  2 in total

1.  Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  A S Lübbe; N Schwella; H Riess; D Huhn
Journal:  Blut       Date:  1990-12

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.